NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search
Avolynt Inc.
Avolynt is developing a novel SGLT2 inhibitor for the treatment of nonalcoholic steatohepatitis (NASH) and type 2 diabetes.
Company Classification
Company type
Bioscience CompanyYear founded
2015Employment in NC
1-19US headquarters
North CarolinaGlobal headquarters
United StatesCompany activities
Research and Development
